Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)

NCT01628614 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT01628614
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01628614 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Intraocular Pressure (IOP) Reduction in Newly Diagnosed Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT)
Lead sponsor
Allergan
Phase
Observational
Overall status
Completed
Start date
November 30, 2010
Completion date
July 31, 2011
Enrollment
4,812 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, open-angle, ocular hypertension